107 related articles for article (PubMed ID: 8280095)
41. Induction of tumor cytotoxicity in murine bone marrow-derived macrophages by two synthetic lipopeptide analogues.
Hoffmann P; Wiesmüller KH; Metzger J; Jung G; Bessler WG
Biol Chem Hoppe Seyler; 1989 Jun; 370(6):575-82. PubMed ID: 2775484
[TBL] [Abstract][Full Text] [Related]
42. Direct activation of murine peritoneal macrophages for nitric oxide production and tumor cell killing by interferon-gamma.
Dileepan KN; Page JC; Li Y; Stechschulte DJ
J Interferon Cytokine Res; 1995 May; 15(5):387-94. PubMed ID: 7648440
[TBL] [Abstract][Full Text] [Related]
43. Identification and characterization of lipopolysaccharide in acetic acid bacteria.
Taniguchi Y; Nishizawa T; Kouhchi C; Inagawa H; Yamaguchi T; Nagai S; Tamura A; Soma G
Anticancer Res; 2006; 26(6A):3997-4002. PubMed ID: 17195448
[TBL] [Abstract][Full Text] [Related]
44. Estrogen attenuates lipopolysaccharide-induced nitric oxide production in macrophages partially via the nongenomic pathway.
Liu L; Wang Z
Cell Immunol; 2013; 286(1-2):53-8. PubMed ID: 24321566
[TBL] [Abstract][Full Text] [Related]
45. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration.
Mühlradt PF; Kiess M; Meyer H; Süssmuth R; Jung G
J Exp Med; 1997 Jun; 185(11):1951-8. PubMed ID: 9166424
[TBL] [Abstract][Full Text] [Related]
46. Lipopolysaccharide inhibits the binding of colony-stimulating factor (CSF-1) to murine peritoneal exudate macrophages.
Chen BD; Lin HS; Hsu S
J Immunol; 1983 May; 130(5):2256-60. PubMed ID: 6300241
[TBL] [Abstract][Full Text] [Related]
47. Identification of S-(2,3-dihydroxypropyl)cystein in a macrophage-activating lipopeptide from Mycoplasma fermentans.
Mühlradt PF; Meyer H; Jansen R
Biochemistry; 1996 Jun; 35(24):7781-6. PubMed ID: 8672478
[TBL] [Abstract][Full Text] [Related]
48. Structure and specific activity of macrophage-stimulating lipopeptides from Mycoplasma hyorhinis.
Mühlradt PF; Kiess M; Meyer H; Süssmuth R; Jung G
Infect Immun; 1998 Oct; 66(10):4804-10. PubMed ID: 9746582
[TBL] [Abstract][Full Text] [Related]
49. Endotoxin suppresses expression of apoprotein E by mouse macrophages in vivo and in culture. A biochemical and genetic study.
Werb Z; Chin JR
J Biol Chem; 1983 Sep; 258(17):10642-8. PubMed ID: 6350291
[TBL] [Abstract][Full Text] [Related]
50. Lipopolysaccharide and tumor necrosis factor-alpha induce lipopolysaccharide receptor expression on bone marrow cells by different mechanisms.
Chaby R; Pedron T; Stütz PL; Girard R
J Immunol; 1993 Nov; 151(9):4476-85. PubMed ID: 7691950
[TBL] [Abstract][Full Text] [Related]
51. Immunostimulation of C3H/HeJ lymphoid cells by R-chemotype lipopolysaccharide preparations.
Flebbe L; Vukajlovich SW; Morrison DC
J Immunol; 1989 Jan; 142(2):642-52. PubMed ID: 2642946
[TBL] [Abstract][Full Text] [Related]
52. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
Fogler WE; Talmadge JE; Fidler IJ
J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
[TBL] [Abstract][Full Text] [Related]
53. Glycosaminoglycan profile of peritoneal and bone marrow-derived macrophages. Changes associated with macrophage activation.
Michelacci YM; Petricevich VL
Comp Biochem Physiol B; 1991; 100(3):617-25. PubMed ID: 1814686
[TBL] [Abstract][Full Text] [Related]
54. Lipopolysaccharide-induced biphasic inositol 1,4,5-trisphosphate response and tyrosine phosphorylation of 140-kilodalton protein in mouse peritoneal macrophages.
Shinji H; Akagawa KS; Tsuji M; Maeda M; Yamada R; Matsuura K; Yamamoto S; Yoshida T
J Immunol; 1997 Feb; 158(3):1370-6. PubMed ID: 9013981
[TBL] [Abstract][Full Text] [Related]
55. Stimulation of phagocytosis in bone marrow-derived mouse macrophages by bacterial lipopolysaccharide: correlation with biochemical and functional parameters.
Cooper PH; Mayer P; Baggiolini M
J Immunol; 1984 Aug; 133(2):913-22. PubMed ID: 6736651
[TBL] [Abstract][Full Text] [Related]
56. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
Hogan MM; Vogel SN
J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
[TBL] [Abstract][Full Text] [Related]
57. Partial restoration of the lipopolysaccharide-induced proliferative response in splenic B cells from C3H/HeJ mice.
Kuus-Reichel K; Ulevitch RJ
J Immunol; 1986 Jul; 137(2):472-7. PubMed ID: 3487572
[TBL] [Abstract][Full Text] [Related]
58. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide.
Sellati TJ; Bouis DA; Kitchens RL; Darveau RP; Pugin J; Ulevitch RJ; Gangloff SC; Goyert SM; Norgard MV; Radolf JD
J Immunol; 1998 Jun; 160(11):5455-64. PubMed ID: 9605148
[TBL] [Abstract][Full Text] [Related]
59. Activation of C3H/HeJ macrophage tumoricidal activity and cytokine release by R-chemotype lipopolysaccharide preparations. Differential effects of IFN-gamma.
Flebbe LM; Chapes SK; Morrison DC
J Immunol; 1990 Sep; 145(5):1505-11. PubMed ID: 2117032
[TBL] [Abstract][Full Text] [Related]
60. Bacterial lipopolysaccharides, phorbol myristate acetate, and zymosan induce the myristoylation of specific macrophage proteins.
Aderem AA; Keum MM; Pure E; Cohn ZA
Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5817-21. PubMed ID: 3461461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
